The central purpose of the Clinical/Experimental Radiation Research Interface Studies (CERRIS) grant is to develop more optimal radiation treatment through the integration of advances in basic science research and clinical investigation leading to the development of a more favorable therapeutic ratio. Although the foremost objective of radiation treatment is ablation of the primary tumor and its regional nodal deposits, thereby improving survival rates, there is a need to preserve vital normal tissues surrounding the cancer to assure high quality of life. Ideally, the therapist would like a predictive index to determine the tumor response as well as the potential for severe normal tissue injury which leads to morbid late effects. The major scientific themes an objectives are enumerated below. The focus in the clinical core section devoted to innovative clinical trials will be demonstrated as being derived from these laboratory themes. A. To define the molecular mechanisms of radiation pathophysiology in critical normal tissues organs such as lung and brain, and thereby identify biochemical events that could serve as early markers for late effects. B. To study the role of intrinsic factors such as intracellular glutathione, thiol depletion and potential lethal repair capacity in tumor radiosensitivity and to determine if, by their manipulation, one can overcome tumor cell radioresistance. C. To evaluate the dynamic cytokinetic parameters in irradiated cancers such as flow cytometric DNA, IudR and K67 to determine potential doubling time, DNA synthesis time and to be able to predict the radiosensitivity of tumor cells, particularly in quiescent phase and the kinetics of their recruitment and proliferative capacities. D. To assess tumor hypoxia, oxygen transport and the manipulation of pathophysiological parameters such as blood flow and hemoglobin affinity for potential therapeutic applications. E. To further define the potential beneficial therapeutic effects of beta interferon by simulating through in vitro experimental models the basis for clinical studies. F. To translate through innovative clinical trials the aforementioned radiobiologic research themes into protocol designs that produce more favorable therapeutic ratios and optimal combined modality therapy with an emphasis on organ preservation and quality of life.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA011051-23
Application #
2085945
Study Section
Special Emphasis Panel (SRC (D1))
Project Start
1977-07-01
Project End
1996-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
23
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Rochester
Department
Radiation-Diagnostic/Oncology
Type
Schools of Dentistry
DUNS #
208469486
City
Rochester
State
NY
Country
United States
Zip Code
14627
Groves, Angela M; Johnston, Carl J; Misra, Ravi S et al. (2015) Whole-Lung Irradiation Results in Pulmonary Macrophage Alterations that are Subpopulation and Strain Specific. Radiat Res 184:639-49
Okunieff, Paul; Xu, Jianhua; Hu, Dongping et al. (2006) Curcumin protects against radiation-induced acute and chronic cutaneous toxicity in mice and decreases mRNA expression of inflammatory and fibrogenic cytokines. Int J Radiat Oncol Biol Phys 65:890-8
Moore, Amy H; Olschowka, John A; Williams, Jacqueline P et al. (2005) Regulation of prostaglandin E2 synthesis after brain irradiation. Int J Radiat Oncol Biol Phys 62:267-72
Okunieff, Paul; Cornelison, Terri; Mester, Marcelo et al. (2005) Mechanism and modification of gastrointestinal soft tissue response to radiation: role of growth factors. Int J Radiat Oncol Biol Phys 62:273-8
Chen, Yuhchyau; Hyrien, Ollivier; Williams, Jacqueline et al. (2005) Interleukin (IL)-1A and IL-6: applications to the predictive diagnostic testing of radiation pneumonitis. Int J Radiat Oncol Biol Phys 62:260-6
Moore, Amy H; Olschowka, John A; Williams, Jacqueline P et al. (2004) Radiation-induced edema is dependent on cyclooxygenase 2 activity in mouse brain. Radiat Res 161:153-60
Ding, Ivan; Liu, Weimin; Sun, Jianzhong et al. (2003) FGF1 and VEGF mediated angiogenesis in KHT tumor-bearing mice. Adv Exp Med Biol 530:603-9
Liang, Li; Hu, Dongping; Liu, Weimin et al. (2003) Celecoxib reduces skin damage after radiation: selective reduction of chemokine and receptor mRNA expression in irradiated skin but not in irradiated mammary tumor. Am J Clin Oncol 26:S114-21
Williams, Jacqueline; Chen, Yuhchyau; Rubin, Philip et al. (2003) The biological basis of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13:182-8
Chen, Yuhchyau; Williams, Jacqueline; Ding, Ivan et al. (2002) Radiation pneumonitis and early circulatory cytokine markers. Semin Radiat Oncol 12:26-33

Showing the most recent 10 out of 15 publications